Sugarcane bagasse lignin, and silica gel and magneto-silica as drug vehicles for development of innocuous methotrexate drug against rheumatoid arthritis disease in albino rats

A facile strategy to fabricate lignocellulose-based slow-release fertilizers via a high-performance treatment of rice straw using deep eutectic solvents

Lignin-based slow-release fertilizers (SRFs) have attracted widespread attention due to their ability to enhance nutrient utilization efficiency and reduce environmental pollution in agricultural production. However, the extraction and separation processes of lignin from biomass sources are intricate, involving substantial quantities of non-reusable toxic reagents. Here, a sustainable and eco-friendly approach using deep eutectic solvents (DES) was employed to treat rice straw, effectively dissolving the lignin present. Subsequently, the in-situ lignin regeneration was facilitated through the addition of a zinc chloride solution. The regenerated lignin was tightly wrapped around and connected to cellulose micro/nanofibers, forming a homogeneous slurry. A simple coating technique was employed to uniformly coat urea particles with the lignocellulosic slurry, yielding lignocellulose-based SRFs. Results revealed that the nutrient release of the lignocellulose-based coated fertilizers in water exceeded 56 days. A pot trial demonstrated that the application of lignocellulose-based SRFs significantly promoted the growth of rice and improved grain yield (by 10.7 %) and nitrogen use efficiency (by 34.4 %) compared to the urea treatment in rice production. Furthermore, the DES demonstrated consistently high efficiency in biomass processing even after four cycles of reuse. This green strategy offers a novel approach for the preparation of SRFs coating materials, promoting agricultural sustainability.

High value-added lignin extracts from sugarcane by-products

This study evaluates the production of lignin bioactive extracts from sugarcane bagasse (SCB) and straw (SCS) alkaline black liquors using greener precipitating agents (methane sulfonic acid (MSA), formic acid (FA) and lactic acid (LA)) as replacers of sulfuric acid (SA), the most common one used in industry. Results showed that the highest precipitation yield was achieved by LA when applied to SCB (14.5 g extract/100 g SCB). Lignin SCB extracts were similar in composition in terms of total carbohydrates (61-70 %), lignin (22-30 %) and inorganics (1.6-2.6 %). Regarding the SCS extracts, similar yields were obtained among all extracts, however, differences in composition were observed between SA and greener precipitating agents, particularly in terms of sugar content. All extracts exhibited radical scavenging activity; overall the extracts were more effective in the scavenging of ABTS radical. FA was the most promising alternative to SA to recover lignin bioactive extracts. This work suggests organic acids as good candidates for obtaining valuable extracts from alkaline pulping of SCB and SCS instead of the conventional sulfuric acid.

Sustainable lignin and lignin-derived compounds as potential therapeutic agents for degenerative orthopaedic diseases: A systemic review

Lignin, the most abundant natural and sustainable phenolic compound in biomass, has exhibited medicinal values due to its biological activities decided by physicochemical properties. Recently, the lignin and its derivatives (such as lignosulfonates and lignosulfonate) have been proven efficient in regulating cellular process and the extracellular microenvironment, which has been regarded as the key factor in disease progression. In orthopaedic diseases, especially the degenerative diseases represented by osteoarthritis and osteoporosis, excessive activated inflammation has been proven as a key stage in the pathological process. Due to the excellent biocompatibility, antibacterial and antioxidative activities of lignin and its derivatives, they have been applied to stimulate cells and restore the uncoupling bone remodeling in the degenerative orthopaedic diseases. However, there is a lack of a systemic review to state the current research actuality of lignin and lignin-derived compounds in treating degenerative orthopaedic diseases. Herein, we summarized the current application of lignin and lignin-derived compounds in orthopaedic diseases and proposed their possible therapeutic mechanism in treating degenerative orthopaedic diseases. It is hoped this work could guide the future preparation of lignin/lignin-derived drugs and implants as available therapeutic strategies for clinically degenerative orthopaedic diseases.

Lignin to Materials: A Focused Review on Recent Novel Lignin Applications

In recent decades, advancements in lignin application include the synthesis of polymers, dyes, adhesives and fertilizers. There has recently been a shift from perceiving lignin as a waste product to viewing lignin as a potential raw material for valuable products. More recently, considerable attention has been placed in sectors, like the medical, electrochemical, and polymer sectors, where lignin can be significantly valorized. Despite some technical challenges in lignin recovery and depolymerization, lignin is viewed as a promising material due to it being biocompatible, cheap, and abundant in nature. In the medical sector, lignins can be used as wound dressings, pharmaceuticals, and drug delivery materials. They can also be used for electrochemical energy materials and 3D printing lignin–plastic composite materials. This review covers the recent research progress in lignin valorization, specifically focusing on medical, electrochemical, and 3D printing applications. The technoeconomic assessment of lignin application is also discussed.

Application of either nano fibrillated cellulose methotrexate or nano silicon dioxide methotrexate composites against renal fibrosis in leukemia rat model

Cellulose derivatives have got growing interest due to their relative abundance and ability to sustain the release of medicaments. In this study, micro- and nano-fibrillated cellulose were prepared from rice straw and used as drug carriers. Both carriers in addition to another one which is nano silicon dioxide were characterized with various techniques. Methotrexate was chosen to be loaded on nano-fibrillated cellulose and nano silicon dioxide. Both methotrexate carriers were evaluated for their possible protective role against renal fibrosis induced by methotrexate in leukemia rat model. Results of this study exhibited that loading methotrexate on either nano-fibrillated cellulose or nano silicon dioxide seems to have an ameliorative role on renal function tests, inflammatory and fibrotic markers of renal tissues. Moreover, the sustained release of methotrexate for long time period maintained by nano-fibrillated cellulose carrier gives it more priority than nano silicon dioxide to be used as an effective novel drug carrier in further medical applications with minimal side effects on kidney tissue in leukemia model.

Lignin for Nano- and Microscaled Carrier Systems: Applications, Trends, and Challenges

To liberate society from its dependence on fossil-based fuels and materials it is pivotal to explore components of renewable plant biomass in applications that benefit from their intrinsic biodegradability, safety, and sustainability. Lignin, a byproduct of the pulp and paper industry, is a plausible material for carrying various types of cargo in small- and large-scale applications. Herein, possibilities and constraints regarding the physical-chemical properties of the lignin source as well as modifications and processing required to render lignins suitable for the loading and release of pesticides, pharmaceuticals, and biological macromolecules is reviewed. In addition, the technical challenges, regulatory and toxicological aspects, and future research needed to realize some of the promises that nano- and microscaled lignin materials hold for a sustainable future are critically discussed.

Lignins and Their Derivatives with Beneficial Effects on Human Health

A review of the pharmacological applications of lignins provides evidence of their protective role against the development of different diseases. In many cases, the effects of lignins could be explained by their antioxidant capacity. Here, we present a systematic review of the literature from the period 2010–2016 which provides information concerning new applications of lignins derived from recent research. The most promising findings are reported, including the methodologies employed and results obtained with lignins or their derivatives which may improve human health. We highlight potential applications in the treatment of obesity, diabetes, thrombosis, viral infections and cancer. Moreover, we report both that lignins can be used in the preparation of nanoparticles to deliver different drugs and also their use in photoprotection.

Nanomedicine delivers promising treatments for rheumatoid arthritis

An increased understanding in the pathophysiology of chronic inflammatory diseases, such as rheumatoid arthritis, reveals that the diseased tissue and the increased presence of macrophages and other overexpressed molecules within the tissue can be exploited to enhance the delivery of nanomedicine. Nanomedicine can passively accumulate into chronic inflammatory tissues via the enhanced permeability and retention phenomenon, or be surface conjugated with a ligand to actively bind to receptors overexpressed by cells within chronic inflammatory tissues, leading to increased efficacy and reduced systemic side-effects. This review highlights the research conducted over the past decade on using nanomedicine for potential treatment of rheumatoid arthritis and summarizes some of the major findings and promising opportunities on using nanomedicine to treat this prevalent and chronic disease.